NIH-funded research NIH-funded research

Developing new contraceptive methods through chemical screening

Official title: CHEMICAL SCREENING AND OPTIMIZATION FACILITY – HIGH THROUGHPUT SCREENING for Contraceptive Targets

Funded at Sri International · NIH-11181775 · Data updated 2026-11-12

This study is working on developing new and safe birth control methods by targeting how eggs and sperm are made, and it aims to create better options for people looking to manage their reproductive health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSri International
NIH-funded
Lab location1 site (Menlo Park, United States)
Project startAugust 1, 2024
Project endJuly 31, 2027
Funding year2024
Award (this year)$713,993
NIH project number75N94023D00006-0-759402400001-1
Project IDNIH-11181775 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive options or those interested in reproductive health advancements.

Less likely to help

Patients who are not seeking contraception or have no interest in reproductive health may not receive benefit from this research.

What this research studies

This research focuses on creating safe and effective contraceptive agents by disrupting key reproductive processes such as oogenesis and spermatogenesis. The team utilizes advanced techniques like high throughput screening to identify and optimize molecular compounds that can serve as contraceptives. Patients may benefit from innovative contraceptive options that are developed through this research, which aims to enhance reproductive health. The project also involves collaboration with various scientific disciplines to ensure comprehensive development of these agents.

Why it matters

Potential benefit: If successful, this research could lead to new contraceptive methods that are safer and more effective for both men and women.

How similar studies have gone: Previous research in contraceptive development has shown promise with similar high throughput screening approaches, indicating potential for success.

Where this research is happening

  • Sri International
    Menlo Park, United States
    Active

Researchers

  • Principal investigator: Gong, Leyi — Sri International
  • Study coordinator: Gong, Leyi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.